The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2018 | Screening for lung cancer in the UK: progress and considerations
The early detection of lung cancer is an exciting field with the potential to greatly improve patient survival. Currently, the topic of screening dominates the agenda in this area, and several countries have already begun to implement screening. Here, Neal Navani, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, discusses whether the UK will follow suit. Dr Navani also highlights the need to consider smoking cessation programmes within screening. This video was recorded at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.
